IBDEI2TS ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,45067,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45067,1,3,0)
;;=3^Sezary Disease,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,45067,1,4,0)
;;=4^C84.19
;;^UTILITY(U,$J,358.3,45067,2)
;;=^5001640
;;^UTILITY(U,$J,358.3,45068,0)
;;=C84.13^^170^2245^29
;;^UTILITY(U,$J,358.3,45068,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45068,1,3,0)
;;=3^Sezary Disease,Intra-Abdominal Lymph Nodes
;;^UTILITY(U,$J,358.3,45068,1,4,0)
;;=4^C84.13
;;^UTILITY(U,$J,358.3,45068,2)
;;=^5001634
;;^UTILITY(U,$J,358.3,45069,0)
;;=C84.16^^170^2245^30
;;^UTILITY(U,$J,358.3,45069,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45069,1,3,0)
;;=3^Sezary Disease,Intrapelvic Lymph Nodes
;;^UTILITY(U,$J,358.3,45069,1,4,0)
;;=4^C84.16
;;^UTILITY(U,$J,358.3,45069,2)
;;=^5001637
;;^UTILITY(U,$J,358.3,45070,0)
;;=C84.12^^170^2245^31
;;^UTILITY(U,$J,358.3,45070,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45070,1,3,0)
;;=3^Sezary Disease,Intrathoracic Lymph Nodes
;;^UTILITY(U,$J,358.3,45070,1,4,0)
;;=4^C84.12
;;^UTILITY(U,$J,358.3,45070,2)
;;=^5001633
;;^UTILITY(U,$J,358.3,45071,0)
;;=C84.14^^170^2245^25
;;^UTILITY(U,$J,358.3,45071,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45071,1,3,0)
;;=3^Sezary Disease,Axilla/Upper Limb Lymph Nodes
;;^UTILITY(U,$J,358.3,45071,1,4,0)
;;=4^C84.14
;;^UTILITY(U,$J,358.3,45071,2)
;;=^5001635
;;^UTILITY(U,$J,358.3,45072,0)
;;=C84.11^^170^2245^27
;;^UTILITY(U,$J,358.3,45072,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45072,1,3,0)
;;=3^Sezary Disease,Head/Face/Neck Lymph Nodes
;;^UTILITY(U,$J,358.3,45072,1,4,0)
;;=4^C84.11
;;^UTILITY(U,$J,358.3,45072,2)
;;=^5001632
;;^UTILITY(U,$J,358.3,45073,0)
;;=C84.15^^170^2245^28
;;^UTILITY(U,$J,358.3,45073,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45073,1,3,0)
;;=3^Sezary Disease,Inguinal Region/LE Lymph Nodes
;;^UTILITY(U,$J,358.3,45073,1,4,0)
;;=4^C84.15
;;^UTILITY(U,$J,358.3,45073,2)
;;=^5001636
;;^UTILITY(U,$J,358.3,45074,0)
;;=C84.18^^170^2245^32
;;^UTILITY(U,$J,358.3,45074,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45074,1,3,0)
;;=3^Sezary Disease,Multiple Site Lymph Nodes
;;^UTILITY(U,$J,358.3,45074,1,4,0)
;;=4^C84.18
;;^UTILITY(U,$J,358.3,45074,2)
;;=^5001639
;;^UTILITY(U,$J,358.3,45075,0)
;;=C84.17^^170^2245^33
;;^UTILITY(U,$J,358.3,45075,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45075,1,3,0)
;;=3^Sezary Disease,Spleen
;;^UTILITY(U,$J,358.3,45075,1,4,0)
;;=4^C84.17
;;^UTILITY(U,$J,358.3,45075,2)
;;=^5001638
;;^UTILITY(U,$J,358.3,45076,0)
;;=C84.10^^170^2245^34
;;^UTILITY(U,$J,358.3,45076,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45076,1,3,0)
;;=3^Sezary Disease,Unspec Site
;;^UTILITY(U,$J,358.3,45076,1,4,0)
;;=4^C84.10
;;^UTILITY(U,$J,358.3,45076,2)
;;=^5001631
;;^UTILITY(U,$J,358.3,45077,0)
;;=A53.9^^170^2245^50
;;^UTILITY(U,$J,358.3,45077,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45077,1,3,0)
;;=3^Syphilis,Unspec
;;^UTILITY(U,$J,358.3,45077,1,4,0)
;;=4^A53.9
;;^UTILITY(U,$J,358.3,45077,2)
;;=^5000310
;;^UTILITY(U,$J,358.3,45078,0)
;;=I87.2^^170^2245^41
;;^UTILITY(U,$J,358.3,45078,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45078,1,3,0)
;;=3^Stasis Dermatitis NOS
;;^UTILITY(U,$J,358.3,45078,1,4,0)
;;=4^I87.2
;;^UTILITY(U,$J,358.3,45078,2)
;;=^5008047
;;^UTILITY(U,$J,358.3,45079,0)
;;=L90.5^^170^2245^18
;;^UTILITY(U,$J,358.3,45079,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2TS 3781 printed Apr 09, 2024@21:00:49 Page 2
IBDEI2TS ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,45067,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,45067,1,3,0)
+4 ;;=3^Sezary Disease,Extranodal/Solid Organ Sites
+5 ;;^UTILITY(U,$J,358.3,45067,1,4,0)
+6 ;;=4^C84.19
+7 ;;^UTILITY(U,$J,358.3,45067,2)
+8 ;;=^5001640
+9 ;;^UTILITY(U,$J,358.3,45068,0)
+10 ;;=C84.13^^170^2245^29
+11 ;;^UTILITY(U,$J,358.3,45068,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,45068,1,3,0)
+14 ;;=3^Sezary Disease,Intra-Abdominal Lymph Nodes
+15 ;;^UTILITY(U,$J,358.3,45068,1,4,0)
+16 ;;=4^C84.13
+17 ;;^UTILITY(U,$J,358.3,45068,2)
+18 ;;=^5001634
+19 ;;^UTILITY(U,$J,358.3,45069,0)
+20 ;;=C84.16^^170^2245^30
+21 ;;^UTILITY(U,$J,358.3,45069,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,45069,1,3,0)
+24 ;;=3^Sezary Disease,Intrapelvic Lymph Nodes
+25 ;;^UTILITY(U,$J,358.3,45069,1,4,0)
+26 ;;=4^C84.16
+27 ;;^UTILITY(U,$J,358.3,45069,2)
+28 ;;=^5001637
+29 ;;^UTILITY(U,$J,358.3,45070,0)
+30 ;;=C84.12^^170^2245^31
+31 ;;^UTILITY(U,$J,358.3,45070,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,45070,1,3,0)
+34 ;;=3^Sezary Disease,Intrathoracic Lymph Nodes
+35 ;;^UTILITY(U,$J,358.3,45070,1,4,0)
+36 ;;=4^C84.12
+37 ;;^UTILITY(U,$J,358.3,45070,2)
+38 ;;=^5001633
+39 ;;^UTILITY(U,$J,358.3,45071,0)
+40 ;;=C84.14^^170^2245^25
+41 ;;^UTILITY(U,$J,358.3,45071,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,45071,1,3,0)
+44 ;;=3^Sezary Disease,Axilla/Upper Limb Lymph Nodes
+45 ;;^UTILITY(U,$J,358.3,45071,1,4,0)
+46 ;;=4^C84.14
+47 ;;^UTILITY(U,$J,358.3,45071,2)
+48 ;;=^5001635
+49 ;;^UTILITY(U,$J,358.3,45072,0)
+50 ;;=C84.11^^170^2245^27
+51 ;;^UTILITY(U,$J,358.3,45072,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,45072,1,3,0)
+54 ;;=3^Sezary Disease,Head/Face/Neck Lymph Nodes
+55 ;;^UTILITY(U,$J,358.3,45072,1,4,0)
+56 ;;=4^C84.11
+57 ;;^UTILITY(U,$J,358.3,45072,2)
+58 ;;=^5001632
+59 ;;^UTILITY(U,$J,358.3,45073,0)
+60 ;;=C84.15^^170^2245^28
+61 ;;^UTILITY(U,$J,358.3,45073,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,45073,1,3,0)
+64 ;;=3^Sezary Disease,Inguinal Region/LE Lymph Nodes
+65 ;;^UTILITY(U,$J,358.3,45073,1,4,0)
+66 ;;=4^C84.15
+67 ;;^UTILITY(U,$J,358.3,45073,2)
+68 ;;=^5001636
+69 ;;^UTILITY(U,$J,358.3,45074,0)
+70 ;;=C84.18^^170^2245^32
+71 ;;^UTILITY(U,$J,358.3,45074,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,45074,1,3,0)
+74 ;;=3^Sezary Disease,Multiple Site Lymph Nodes
+75 ;;^UTILITY(U,$J,358.3,45074,1,4,0)
+76 ;;=4^C84.18
+77 ;;^UTILITY(U,$J,358.3,45074,2)
+78 ;;=^5001639
+79 ;;^UTILITY(U,$J,358.3,45075,0)
+80 ;;=C84.17^^170^2245^33
+81 ;;^UTILITY(U,$J,358.3,45075,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,45075,1,3,0)
+84 ;;=3^Sezary Disease,Spleen
+85 ;;^UTILITY(U,$J,358.3,45075,1,4,0)
+86 ;;=4^C84.17
+87 ;;^UTILITY(U,$J,358.3,45075,2)
+88 ;;=^5001638
+89 ;;^UTILITY(U,$J,358.3,45076,0)
+90 ;;=C84.10^^170^2245^34
+91 ;;^UTILITY(U,$J,358.3,45076,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,45076,1,3,0)
+94 ;;=3^Sezary Disease,Unspec Site
+95 ;;^UTILITY(U,$J,358.3,45076,1,4,0)
+96 ;;=4^C84.10
+97 ;;^UTILITY(U,$J,358.3,45076,2)
+98 ;;=^5001631
+99 ;;^UTILITY(U,$J,358.3,45077,0)
+100 ;;=A53.9^^170^2245^50
+101 ;;^UTILITY(U,$J,358.3,45077,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,45077,1,3,0)
+104 ;;=3^Syphilis,Unspec
+105 ;;^UTILITY(U,$J,358.3,45077,1,4,0)
+106 ;;=4^A53.9
+107 ;;^UTILITY(U,$J,358.3,45077,2)
+108 ;;=^5000310
+109 ;;^UTILITY(U,$J,358.3,45078,0)
+110 ;;=I87.2^^170^2245^41
+111 ;;^UTILITY(U,$J,358.3,45078,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,45078,1,3,0)
+114 ;;=3^Stasis Dermatitis NOS
+115 ;;^UTILITY(U,$J,358.3,45078,1,4,0)
+116 ;;=4^I87.2
+117 ;;^UTILITY(U,$J,358.3,45078,2)
+118 ;;=^5008047
+119 ;;^UTILITY(U,$J,358.3,45079,0)
+120 ;;=L90.5^^170^2245^18
+121 ;;^UTILITY(U,$J,358.3,45079,1,0)
+122 ;;=^358.31IA^4^2
